REVIEWERS COMMENTS. This large study is one of the few longitudinal studies to have examined the relationship between sibling exposure and allergic rhinitis; most other studies have been cross-sectional. The method of evaluation of sibling exposure quantifies both timing and dose and helps to pinpoint a potentially fruitful area for further research (before 2 years). One limitation is that the specific viral infections recorded for this study did not include viruses that primarily cause airway damage, such as respiratory syncytial virus and influenza. The mechanism for the effect of tonsillectomy is open to speculation. Possibilities include its significance as a marker of antibiotic use or, alternatively, a marker of severe, repeated, upper respiratory infection resulting in inflammation and, therefore, increased risk of sensitization via increased mucosal permeability. METHODS. The subjects were randomly assigned to receive Ն60 mL/day of commercially available cow's milkbased formula either with or without probiotic supplementation from birth to the age of 6 months. The probiotics used were Bifidobacterium longum (10 7 colonyforming units per g) and Lactobacillus rhamnosus (2 ϫ 10 8 colony-forming units per g). The primary outcome was eczema (pruritic rash with chronic relapsing course), and the secondary outcome was allergen sensitization. Questionnaires and pediatrician evaluations were performed at 1, 3, 6, and 12 months. The scoring atopic dermatitis index was used to objectively define the severity of atopic dermatitis. Skin-prick tests (to soy, milk, egg yolk, egg white, and 2 locally prevalent dust mites) were performed at the 12-month visit. The 2 outcomes were compared by using 2 tests, and logistic regression was used to calculate the odds ratio and to adjust for potential confounders (gender, birth order, prenatal smoking exposure, and feeding history).
RESULTS. The incidence of eczema in the probiotic group (22%) was similar to that in the placebo group (25%) (odds ratio: 0.8 [95% confidence interval: 0.4 -1.5]). Severity among those with eczema according to the scoring atopic dermatitis index was not significantly different (P ϭ .17). The rate of sensitization at 1 year showed no difference between the 2 groups (24% [probiotic group] vs 19% [placebo]).
CONCLUSIONS. The results of this study do not support the role of early-life probiotic supplementation as a modality for primary eczema prevention.
REVIEWERS COMMENTS. Studies examining the effect of probiotics on atopy prevention or treatment have shown results ranging from negative (increased wheeze and allergic sensitization with probiotics) to neutral and to positive. Differences between these various studies include characteristics of the study population, probiotic strains and doses used and treatment length, and use of prenatal probiotic supplementation. Attention to these details will be required to draw conclusions about the efficacy of probiotics for prevention/treatment of atopic disease. For now, it seems that the jury is still out. It should be noted that this study used a standard wholeprotein cow's milk formula, rather than a hydrolyzed type that would be recommended for atopy prevention in nonbreastfeeding infants at high risk.
METHODS. Mothers with no chronic or metabolic disease before or during early pregnancy had dietary counseling and were randomly assigned to receive either probiotics (Lactobacillus rhamnosus strain GG and Bifidobacterium lactis Bb12) or placebo from the first trimester of pregnancy to the end of exclusive breastfeeding. Atopic sensitization of the infants was assessed by skin-prick test to cow's milk, egg white, wheat, rice, gliadin, cod, soya bean, birch, 6 grasses, cat, dog, Dermatophagoides pteronyssinus (dust mite), latex, potato, carrot, and banana at the ages of 6 and 12 months. The mothers were skin tested for these antigens as well as peanut, hazelnut, alder, and mugwort in their third trimester of pregnancy. Infants were examined at 1, 6, and 12 months of age. Breast milk samples were collected immediately after birth and 1 month after delivery. Concentrations of transforming growth factor ␤ 2 (TGF-␤ 2 ) and soluble CD14 were measured in breast milk by using commercial sandwich enzyme-linked immunosorbent assays. The concentrations of interferon ␥, tumor necrosis factor ␣, interleukin (IL)-10, IL-6, IL-4, and IL-2 were measured via flow cytometry. Infant sensitization assessed by skin-prick test at the age of 12 months was the primary variable. The effects of probiotic intervention, allergy status of the mother, and duration of total and exclusive breastfeeding on infant sensitization were analyzed by using the 2 test. The t test for independent samples was used to compare the probiotic and placebo groups.
RESULTS. At the age of 12 months, 30% of the infants showed Ն1 positive reactions on the skin-prick test. Allergic disease and positive skin-prick test results in the mother were likely to be associated with increased risk of sensitization in the child. The total duration of breastfeeding affected the risk of sensitization in the infant according to the allergy status of the mother; the risk of sensitization increased for infants with allergic mothers breastfeeding for Ͼ6 months or exclusively breastfeeding for Ͼ2.5 months (odds ratio: 4.8; P ϭ .005). Probiotic supplementation had a protective effect against sensitization in infants with mothers with sensitization. The concentration of TGF-␤ 2 tended to be higher in the colostrum of the mothers in the probiotic group, compared with those in the placebo group (probiotic/placebo ratio: 1.5; P ϭ .02). A low level of TGF-␤ 2 in the colostrum seemed to be associated with a positive skinprick test result in the infant. Probiotic supplementation had a protective effect against sensitization in a subgroup of infants with maternal sensitization: 26% of the infants in the probiotic group versus 50% in the placebo group had positive skin-prick test results. Atopic eczema was diagnosed at the age of 12 months in 9.7% of the infants in the probiotic group and in 17.6% of the infants in the placebo group.
CONCLUSIONS. Maternal skin-prick test reactivity accompanied by allergic disease may increase infant vulnerability to sensitization. Breastfeeding by atopic mothers increases the likelihood of sensitization in infants. Probiotics provide protection from sensitization in infants at high risk.
REVIEWERS COMMENTS. The authors of this article raise interesting questions about the impact of breast milk in the prevention of atopic disease. They noted a protective benefit of probiotic supplementation in their study population and theorized that the possible mechanism for this protective effect is through an increase in antiinflammatory TGF-␤ 2 in breast milk. The authors noted possible limitations of probiotics, including appropriate selections of antiinflammatory probiotic strains and risk of disease in the infant. This is a fascinating area for future study.
PURPOSE OF THE STUDY. To investigate the relationship between allergen-specific cord blood (CB) immunoglobulin E (IgE) levels, parental allergen sensitization, CB cytokine production, and environmental influences.
STUDY POPULATION. This study included families recruited for the multicenter Protection Against Allergy-Study in Rural Environments (PASTURE) study, an ongoing longitudinal birth cohort study designed to evaluate risk factors and preventative factors for atopic disease. Pregnant women in their third trimester were recruited for participation from Finland, Germany, France, Switzerland, and Austria.
METHODS. CB samples were collected from umbilical cord veins, and parental blood samples were collected by peripheral vein puncture; the levels of allergen-specific IgE against 20 common inhalant and food allergens were measured by using the Allergy Screen (Mediwiss Analytic, Moers, Germany) test panel for atopy. The Allergy Screen result was compared with the skin-prick test result and showed a concordance of 92%. Serum IgA levels were determined by immunoturbidimetry. CB samples were stimulated by using astandardized protocol
